Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-47.37%
0%
-47.37%
6 Months
-47.37%
0%
-47.37%
1 Year
-66.67%
0%
-66.67%
2 Years
-69.7%
0%
-69.7%
3 Years
-90.65%
0%
-90.65%
4 Years
-95.78%
0%
-95.78%
5 Years
-95.37%
0%
-95.37%
Can-Fite BioPharma Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-27.66%
EBIT Growth (5y)
-14.59%
EBIT to Interest (avg)
-39.36
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.44
Sales to Capital Employed (avg)
0.11
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.18
EV to EBIT
-0.30
EV to EBITDA
-0.30
EV to Capital Employed
-1.22
EV to Sales
3.33
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-198.87%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.






